Kin Ventures

Kin Ventures, established in 2021 and located in San Francisco, California, is a venture capital firm that focuses on connecting capital with talent. The firm specializes in investments across various sectors, including business-to-business (B2B), business-to-consumer (B2C), information technology, healthcare, financial services, clean technology, digital health, e-commerce, and supply chain technology. As a Registered Investment Adviser, Kin Ventures aims to identify and support innovative companies that demonstrate potential for growth and impact in their respective fields.

Dhruv Asher

Venture Partner

Ben Herman

Partner

Tina Hoang-To

Partner

4 past transactions

Rippl Care

Series A in 2024
Rippl Care is a mental health company based in Seattle, Washington, dedicated to supporting seniors experiencing dementia and other neurocognitive disorders. Founded in 2021, the company employs a value-based approach and innovative technology to deliver comprehensive care tailored to individual needs. By prioritizing the empowerment of its clinicians, Rippl Care adopts a novel care model that enables seniors to receive personalized support through various channels, including phone, online, and in-home visits. This commitment to enhancing the quality of care for those affected by neurocognitive conditions sets Rippl Care apart in the mental health landscape.

Adonis

Series B in 2024
Adonis is a healthcare revenue intelligence and automation platform that addresses operational challenges in revenue cycle management (RCM). Many healthcare providers struggle to collect a significant portion of the revenue they are owed, often losing 15% or more due to inefficiencies within traditional RCM systems. Adonis leverages data science and artificial intelligence to streamline processes, automate tasks, detect underpayments, and enhance claim accuracy. By focusing on these critical areas, the platform aims to optimize financial outcomes for medical providers, reducing administrative burdens and allowing them to concentrate on patient care.

Power Life Science

Series A in 2023
Power Life Science believes that every patient deserves the chance to participate in a life-changing clinical trial. Is backed by some of the best healthcare investors and operators with a range of experience across clinical research and biopharmaceuticals. We are a small team - each of us with our own personal story and motivation to make a difference in the lives of patients.

Edge Delta

Series B in 2022
Edge Delta Inc. is a technology company that specializes in artificial intelligence-based software for data analysis and security services. Founded in 2018 and headquartered in Seattle, Washington, the company offers an observability automation platform that enables DevOps, Developer, and Site Reliability Engineering (SRE) teams to efficiently monitor and manage data without the need to replicate or transmit sensitive datasets. By employing federated learning, Edge Delta's software processes data at the source, enhancing security while providing valuable analytics. The platform captures and shapes data in-flight, automatically detecting anomalies and summarizing log data to identify operational and security incidents. This innovative approach helps clients mitigate blind spots, control costs, and adapt to data growth, moving beyond the limitations of traditional centralized systems.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.